valgan

Antiviral

Description
Shipping Options
Customer Reviews

Introduction:

Valgan is an antiviral medication containing Valganciclovir, a prodrug of ganciclovir. It is primarily used to treat cytomegalovirus (CMV) infections, especially in immunocompromised patients (e.g., HIV/AIDS, organ transplant recipients).

Description:

Generic Name: Valganciclovir
Brand Name: Valgan
Drug Class: Antiviral (Nucleoside analogue)
Mechanism of Action:
- Converts into ganciclovir, which inhibits CMV DNA polymerase, preventing viral replication.

Therapeutic Uses:

CMV Retinitis (in HIV Patients)
Prevention of CMV Disease in Organ Transplant Recipients
- Kidney, heart, or pancreas transplants
Congenital CMV Infection (in some cases)

Dosage:

Condition	Dosage	Duration
CMV Retinitis (Induction)	900 mg twice daily	21 days
CMV Retinitis (Maintenance)	900 mg once daily	Long-term
CMV Prophylaxis (Transplant Patients)	900 mg once daily	100–200 days post-transplant
Renal Dose Adjustment	Required (lower dose if impaired kidney function)	As prescribed

Side Effects:

Common:

Bone Marrow Suppression (↓ Neutrophils, ↓ Platelets, ↓ Hemoglobin)
Diarrhea, nausea, vomiting
Fever, headache, fatigue

Serious (Require Medical Attention):

Severe neutropenia/pancytopenia (risk of infections/bleeding)
Kidney toxicity (monitor creatinine)
Seizures, hallucinations (CNS effects)
Retinal detachment (in CMV retinitis patients)

Important Warnings:

Hematologic Toxicity: Regular CBC monitoring required (risk of neutropenia, anemia, thrombocytopenia).
Teratogenic: Contraindicated in pregnancy (Category D – can cause fetal harm).
Carcinogenic/Mutagenic: Long-term use may increase cancer risk.
Drug Interactions:
- Myelosuppressive drugs (e.g., zidovudine, trimethoprim-sulfamethoxazole) → Increased toxicity.
- Probenecid → Increases ganciclovir levels.

Storage:

Store at 25°C (77°F), away from moisture.
Keep in original packaging (light-sensitive).
Keep out of reach of children & pets.

Conclusion:

Valgan (Valganciclovir) is a potent anti-CMV drug used in immunocompromised patients. Due to its high toxicity risk, strict monitoring of blood counts and kidney function is essential.

Would you like details on pediatric dosing or alternative CMV treatments?

Introduction:

Description:

Generic Name: Valganciclovir
Brand Name: Valgan
Drug Class: Antiviral (Nucleoside analogue)
Mechanism of Action:
- Converts into ganciclovir, which inhibits CMV DNA polymerase, preventing viral replication.

Therapeutic Uses:

CMV Retinitis (in HIV Patients)
Prevention of CMV Disease in Organ Transplant Recipients
- Kidney, heart, or pancreas transplants
Congenital CMV Infection (in some cases)

Dosage:

Condition	Dosage	Duration
CMV Retinitis (Induction)	900 mg twice daily	21 days
CMV Retinitis (Maintenance)	900 mg once daily	Long-term
CMV Prophylaxis (Transplant Patients)	900 mg once daily	100–200 days post-transplant
Renal Dose Adjustment	Required (lower dose if impaired kidney function)	As prescribed

Side Effects:

Common:

Bone Marrow Suppression (↓ Neutrophils, ↓ Platelets, ↓ Hemoglobin)
Diarrhea, nausea, vomiting
Fever, headache, fatigue

Serious (Require Medical Attention):

Severe neutropenia/pancytopenia (risk of infections/bleeding)
Kidney toxicity (monitor creatinine)
Seizures, hallucinations (CNS effects)
Retinal detachment (in CMV retinitis patients)

Important Warnings:

Hematologic Toxicity: Regular CBC monitoring required (risk of neutropenia, anemia, thrombocytopenia).
Teratogenic: Contraindicated in pregnancy (Category D – can cause fetal harm).
Carcinogenic/Mutagenic: Long-term use may increase cancer risk.
Drug Interactions:
- Myelosuppressive drugs (e.g., zidovudine, trimethoprim-sulfamethoxazole) → Increased toxicity.
- Probenecid → Increases ganciclovir levels.

Storage:

Store at 25°C (77°F), away from moisture.
Keep in original packaging (light-sensitive).
Keep out of reach of children & pets.

Conclusion:

Valgan (Valganciclovir) is a potent anti-CMV drug used in immunocompromised patients. Due to its high toxicity risk, strict monitoring of blood counts and kidney function is essential.

Would you like details on pediatric dosing or alternative CMV treatments?

Shipping Options –

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions –

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Description
Reviews (0)

Introduction:

Description:

Generic Name: Valganciclovir
Brand Name: Valgan
Drug Class: Antiviral (Nucleoside analogue)
Mechanism of Action:
- Converts into ganciclovir, which inhibits CMV DNA polymerase, preventing viral replication.

Therapeutic Uses:

CMV Retinitis (in HIV Patients)
Prevention of CMV Disease in Organ Transplant Recipients
- Kidney, heart, or pancreas transplants
Congenital CMV Infection (in some cases)

Dosage:

Condition	Dosage	Duration
CMV Retinitis (Induction)	900 mg twice daily	21 days
CMV Retinitis (Maintenance)	900 mg once daily	Long-term
CMV Prophylaxis (Transplant Patients)	900 mg once daily	100–200 days post-transplant
Renal Dose Adjustment	Required (lower dose if impaired kidney function)	As prescribed

Side Effects:

Common:

Bone Marrow Suppression (↓ Neutrophils, ↓ Platelets, ↓ Hemoglobin)
Diarrhea, nausea, vomiting
Fever, headache, fatigue

Serious (Require Medical Attention):

Severe neutropenia/pancytopenia (risk of infections/bleeding)
Kidney toxicity (monitor creatinine)
Seizures, hallucinations (CNS effects)
Retinal detachment (in CMV retinitis patients)

Important Warnings:

Hematologic Toxicity: Regular CBC monitoring required (risk of neutropenia, anemia, thrombocytopenia).
Teratogenic: Contraindicated in pregnancy (Category D – can cause fetal harm).
Carcinogenic/Mutagenic: Long-term use may increase cancer risk.
Drug Interactions:
- Myelosuppressive drugs (e.g., zidovudine, trimethoprim-sulfamethoxazole) → Increased toxicity.
- Probenecid → Increases ganciclovir levels.

Storage:

Store at 25°C (77°F), away from moisture.
Keep in original packaging (light-sensitive).
Keep out of reach of children & pets.

Conclusion:

Valgan (Valganciclovir) is a potent anti-CMV drug used in immunocompromised patients. Due to its high toxicity risk, strict monitoring of blood counts and kidney function is essential.

Would you like details on pediatric dosing or alternative CMV treatments?

Reviews

There are no reviews yet.

Be the first to review “valgan”

Description
Reviews (0)

Introduction:

Description:

Generic Name: Valganciclovir
Brand Name: Valgan
Drug Class: Antiviral (Nucleoside analogue)
Mechanism of Action:
- Converts into ganciclovir, which inhibits CMV DNA polymerase, preventing viral replication.

Therapeutic Uses:

CMV Retinitis (in HIV Patients)
Prevention of CMV Disease in Organ Transplant Recipients
- Kidney, heart, or pancreas transplants
Congenital CMV Infection (in some cases)

Dosage:

Condition	Dosage	Duration
CMV Retinitis (Induction)	900 mg twice daily	21 days
CMV Retinitis (Maintenance)	900 mg once daily	Long-term
CMV Prophylaxis (Transplant Patients)	900 mg once daily	100–200 days post-transplant
Renal Dose Adjustment	Required (lower dose if impaired kidney function)	As prescribed

Side Effects:

Common:

Bone Marrow Suppression (↓ Neutrophils, ↓ Platelets, ↓ Hemoglobin)
Diarrhea, nausea, vomiting
Fever, headache, fatigue

Serious (Require Medical Attention):

Severe neutropenia/pancytopenia (risk of infections/bleeding)
Kidney toxicity (monitor creatinine)
Seizures, hallucinations (CNS effects)
Retinal detachment (in CMV retinitis patients)

Important Warnings:

Hematologic Toxicity: Regular CBC monitoring required (risk of neutropenia, anemia, thrombocytopenia).
Teratogenic: Contraindicated in pregnancy (Category D – can cause fetal harm).
Carcinogenic/Mutagenic: Long-term use may increase cancer risk.
Drug Interactions:
- Myelosuppressive drugs (e.g., zidovudine, trimethoprim-sulfamethoxazole) → Increased toxicity.
- Probenecid → Increases ganciclovir levels.

Storage:

Store at 25°C (77°F), away from moisture.
Keep in original packaging (light-sensitive).
Keep out of reach of children & pets.

Conclusion:

Valgan (Valganciclovir) is a potent anti-CMV drug used in immunocompromised patients. Due to its high toxicity risk, strict monitoring of blood counts and kidney function is essential.

Would you like details on pediatric dosing or alternative CMV treatments?

Reviews

There are no reviews yet.

Be the first to review “valgan”

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.